{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:22:02Z","timestamp":1794273722165,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Struct Mol Biol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41594-018-0180-z","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T13:03:23Z","timestamp":1549371803000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":199,"title":["Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine"],"prefix":"10.1038","volume":"26","author":[{"given":"Kanako Terakado","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6255-4728","authenticated-orcid":false,"given":"Hidetsugu","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9187-4584","authenticated-orcid":false,"given":"Francois Marie Ngako","family":"Kadji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dohyun","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-5440","authenticated-orcid":false,"given":"Takatoshi","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1491-6509","authenticated-orcid":false,"given":"Kunio","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6330-2239","authenticated-orcid":false,"given":"Norimichi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junken","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-2937","authenticated-orcid":false,"given":"So","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-9485","authenticated-orcid":false,"given":"Tatsuro","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"180_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"Berger, M., Gray, J. A. & Roth, B. L. The expanded biology of serotonin. Annu. Rev. Med. 60, 355\u2013366 (2009).","journal-title":"Annu. Rev. Med."},{"key":"180_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0163-7258(98)00019-9","volume":"79","author":"BL Roth","year":"1998","unstructured":"Roth, B. L., Willins, D. L., Kristiansen, K. & Kroeze, W. K. 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol. Ther. 79, 231\u2013257 (1998).","journal-title":"Pharmacol. Ther."},{"key":"180_CR3","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1021\/cr078224o","volume":"108","author":"DE Nichols","year":"2008","unstructured":"Nichols, D. E. & Nichols, C. D. Serotonin receptors. Chem. Rev. 108, 1614\u20131641 (2008).","journal-title":"Chem. Rev."},{"key":"180_CR4","first-page":"604","volume":"38","author":"T Branchek","year":"1990","unstructured":"Branchek, T., Adham, N., Macchi, M., Kao, H. T. & Hartig, P. R. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. Mol. Pharmacol. 38, 604\u2013609 (1990).","journal-title":"Mol. Pharmacol."},{"key":"180_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1517\/13543784.2013.769957","volume":"22","author":"TA Mestre","year":"2013","unstructured":"Mestre, T. A., Zurowski, M. & Fox, S. H. 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders. Expert Opin. Investig. Drugs 22, 411\u2013421 (2013).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"180_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neubiorev.2016.02.008","volume":"64","author":"S Aznar","year":"2016","unstructured":"Aznar, S. & Hervig, M. E. The 5-HT2A serotonin receptor in executive function: implications for neuropsychiatric and neurodegenerative diseases. Neurosci. Biobehav. Rev. 64, 63\u201382 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"180_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","volume":"11","author":"HY Meltzer","year":"2011","unstructured":"Meltzer, H. Y. & Massey, B. W. The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr. Opin. Pharmacol. 11, 59\u201367 (2011).","journal-title":"Curr. Opin. Pharmacol."},{"key":"180_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/sj.npp.1300027","volume":"28","author":"WK Kroeze","year":"2003","unstructured":"Kroeze, W. K. et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28, 519\u2013526 (2003).","journal-title":"Neuropsychopharmacology"},{"key":"180_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth, B. L., Sheffler, D. J. & Kroeze, W. K. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug. Discov. 3, 353\u2013359 (2004).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"180_CR10","first-page":"617","volume":"81","author":"J Muench","year":"2010","unstructured":"Muench, J. & Hamer, A. M. Adverse effects of antipsychotic medications. Am. Fam. Physician 81, 617\u2013622 (2010).","journal-title":"Am. Fam. Physician"},{"key":"180_CR11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s40263-013-0115-5","volume":"27","author":"K Weston-Green","year":"2013","unstructured":"Weston-Green, K., Huang, X. F. & Deng, C. Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor. CNS Drugs 27, 1069\u20131080 (2013).","journal-title":"CNS Drugs"},{"key":"180_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000105135","volume":"24","author":"S Uchiyama","year":"2007","unstructured":"Uchiyama, S., Ozaki, Y., Satoh, K., Kondo, K. & Nishimaru, K. Effect of sarpogrelate, a 5-HT2A antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study. Cerebrovasc. Dis. 24, 264\u2013270 (2007).","journal-title":"Cerebrovasc. Dis."},{"key":"180_CR13","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1172\/JCI70678","volume":"123","author":"HY Meltzer","year":"2013","unstructured":"Meltzer, H. Y. & Roth, B. L. Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs. J. Clin. Invest. 123, 4986\u20134991 (2013).","journal-title":"J. Clin. Invest."},{"key":"180_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/NSS.S6849","volume":"2","author":"KE Vanover","year":"2010","unstructured":"Vanover, K. E. & Davis, R. E. Role of 5-HT2A receptor antagonists in the treatment of insomnia. Nat. Sci. Sleep 2, 139\u2013150 (2010).","journal-title":"Nat. Sci. Sleep"},{"key":"180_CR15","doi-asserted-by":"publisher","first-page":"719-+","DOI":"10.1016\/j.cell.2018.01.001","volume":"172","author":"Y Peng","year":"2018","unstructured":"Peng, Y. et al. 5-HT2C receptor structures reveal the structural basis of GPCR polypharmacology. Cell 172, 719-+ (2018).","journal-title":"Cell"},{"key":"180_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1126\/science.1232808","volume":"340","author":"D Wacker","year":"2013","unstructured":"Wacker, D. et al. Structural features for functional selectivity at serotonin receptors. Science 340, 615\u2013619 (2013).","journal-title":"Science"},{"key":"180_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41421-018-0009-2","volume":"4","author":"W Yin","year":"2018","unstructured":"Yin, W. et al. Crystal structure of the human 5-HT1B serotonin receptor bound to an inverse agonist. Cell Discov. 4, 12 (2018).","journal-title":"Cell Discov."},{"key":"180_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature25758","volume":"555","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature 555, 269\u2013273 (2018).","journal-title":"Nature"},{"key":"180_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature10236","volume":"475","author":"T Shimamura","year":"2011","unstructured":"Shimamura, T. et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 475, 65\u201370 (2011).","journal-title":"Nature"},{"key":"180_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","volume":"25","author":"JA Ballesteros","year":"1995","unstructured":"Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three dimensional models and computational probing of structure\u2013function relations in G protein-coupled receptors. Methods Neurosci. 25, 366\u2013428 (1995).","journal-title":"Methods Neurosci."},{"key":"180_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","volume":"36","author":"V Isberg","year":"2015","unstructured":"Isberg, V. et al. Generic GPCR residue numbers - aligning topology maps while minding the gaps. Trends Pharmacol. Sci. 36, 22\u201331 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"180_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/107385840000600408","volume":"6","author":"BL Roth","year":"2000","unstructured":"Roth, B. L., Lopez, E., Patel, S. & Kroeze, W. K. The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches? The Neuroscientist 6, 252\u2013262 (2000).","journal-title":"The Neuroscientist"},{"key":"180_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1124\/pr.114.009944","volume":"67","author":"M Michino","year":"2015","unstructured":"Michino, M. et al. What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands? Pharmacol. Rev. 67, 198\u2013213 (2015).","journal-title":"Pharmacol. Rev."},{"key":"180_CR24","doi-asserted-by":"publisher","first-page":"e668","DOI":"10.4088\/JCP.16r11119","volume":"78","author":"MV Mathis","year":"2017","unstructured":"Mathis, M. V. et al. The US Food and Drug Administration\u2019s perspective on the new antipsychotic pimavanserin. J. Clin. Psychiatry 78, e668\u2013e673 (2017).","journal-title":"J. Clin. Psychiatry"},{"key":"180_CR25","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1007\/s11064-014-1293-3","volume":"39","author":"U Hacksell","year":"2014","unstructured":"Hacksell, U., Burstein, E. S., McFarland, K., Mills, R. G. & Williams, H. On the discovery and development of pimavanserin: a novel drug candidate for Parkinson\u2019s psychosis. Neurochem. Res. 39, 2008\u20132017 (2014).","journal-title":"Neurochem. Res."},{"key":"180_CR26","first-page":"238","volume":"251","author":"HY Meltzer","year":"1989","unstructured":"Meltzer, H. Y., Matsubara, S. & Lee, J. C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 Pki values. J. Pharmacol. Exp. Ther. 251, 238\u2013246 (1989).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"180_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0022-2836(02)00884-7","volume":"323","author":"R Chu","year":"2002","unstructured":"Chu, R. et al. Redesign of a four-helix bundle protein by phage display coupled with proteolysis and structural characterization by NMR and X-ray crystallography. J. Mol. Biol. 323, 253\u2013262 (2002).","journal-title":"J. Mol. Biol."},{"key":"180_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jmb.2007.12.028","volume":"376","author":"CB Roth","year":"2008","unstructured":"Roth, C. B., Hanson, M. A. & Stevens, R. C. Stabilization of the human beta2-adrenergic receptor TM4TM3TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure. J. Mol. Biol. 376, 1305\u20131319 (2008).","journal-title":"J. Mol. Biol."},{"key":"180_CR29","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1021\/acs.jpcb.7b02997","volume":"121","author":"S Yasuda","year":"2017","unstructured":"Yasuda, S. et al. Hot-spot residues to be mutated common in G protein-coupled receptors of class A: identification of thermostabilizing mutations followed by determination of three-dimensional structures for two example receptors. J. Phys. Chem. B 121, 6341\u20136350 (2017).","journal-title":"J. Phys. Chem. B"},{"key":"180_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1107\/S2059798318004576","volume":"74","author":"K Yamashita","year":"2018","unstructured":"Yamashita, K., Hirata, K. & Yamamoto, M. KAMO: towards automated data processing for microcrystals. Acta Crystallog. D Struct. Biol. 74, 441\u2013449 (2018).","journal-title":"Acta Crystallog. D Struct. Biol."},{"key":"180_CR31","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1107\/S0907444913012274","volume":"69","author":"J Foadi","year":"2013","unstructured":"Foadi, J. et al. Clustering procedures for the optimal selection of data sets from multiple crystals in macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 69, 1617\u20131632 (2013).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"180_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"180_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1107\/S0907444909047374","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D Biol. Crystallogr. 66, 133\u2013144 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"180_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ Mccoy","year":"2007","unstructured":"Mccoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"180_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Struct. Biol. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"180_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"180_CR37","doi-asserted-by":"publisher","first-page":"W375","DOI":"10.1093\/nar\/gkm216","volume":"35","author":"IW Davis","year":"2007","unstructured":"Davis, I. W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375\u2013W383 (2007).","journal-title":"Nucleic Acids Res."},{"key":"180_CR38","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739\u20131749 (2004).","journal-title":"J. Med. Chem."},{"key":"180_CR39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/nmeth.2172","volume":"9","author":"A Inoue","year":"2012","unstructured":"Inoue, A. et al. TGF alpha shedding assay: an accurate and versatile method for detecting GPCR activation. Nat. Methods 9, 1021\u20131029 (2012).","journal-title":"Nat. Methods"},{"key":"180_CR40","doi-asserted-by":"publisher","first-page":"10156","DOI":"10.1038\/ncomms10156","volume":"6","author":"R Schrage","year":"2015","unstructured":"Schrage, R. et al. The experimental power of FR900359 to study Gq-regulated biological processes. Nat. Commun. 6, 10156 (2015).","journal-title":"Nat. Commun."},{"key":"180_CR41","doi-asserted-by":"publisher","first-page":"47438","DOI":"10.1074\/jbc.M408846200","volume":"279","author":"J Takasaki","year":"2004","unstructured":"Takasaki, J. et al. A novel G alpha(q\/11)-selective inhibitor. J. Biol. Chem. 279, 47438\u201347445 (2004).","journal-title":"J. Biol. Chem."},{"key":"180_CR42","first-page":"85","volume":"286","author":"CT Egan","year":"1998","unstructured":"Egan, C. T., Herrick-Davis, K. & Teitler, M. Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs. J. Pharmacol. Exp. Ther. 286, 85\u201390 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"180_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1056-8719(02)00166-1","volume":"46","author":"HC Cheng","year":"2001","unstructured":"Cheng, H. C. The power issue: determination of K-B or K-i from IC50\u2014a closer look at the Cheng-Prusoff equation, the Schild plot and related power equations. J. Pharmacol. Toxicol. Methods 46, 61\u201371 (2001).","journal-title":"J. Pharmacol. Toxicol. Methods"}],"container-title":["Nature Structural &amp; Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41594-018-0180-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41594-018-0180-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41594-018-0180-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:23:28Z","timestamp":1684607008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41594-018-0180-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1038\/s41594-018-0180-z","relation":{},"ISSN":["1545-9993","1545-9985"],"issn-type":[{"value":"1545-9993","type":"print"},{"value":"1545-9985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}